OptimizeRx Corporation (OPRX) Capital expenditures 2016–2025
OptimizeRx Corporation (OPRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$58,000FY2025 · since FY2016: $178,434 → $58,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $58,000 | -48.2% |
| FY2024 | $112,000 | +28.7% |
| FY2023 | $87,000 | +7.4% |
| FY2022 | $81,005 | -19.3% |
| FY2021 | $100,322 | +47.4% |
| FY2020 | $68,041 | -22.4% |
| FY2019 | $87,717 | +155.3% |
| FY2018 | $34,362 | -18.7% |
| FY2017 | $42,243 | -76.3% |
| FY2016 | $178,434 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice